Canna~Fangled Abstracts A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients Journal List Iran J Pharm Res v.21(1); 2022 Dec PMC10024807 Iran J Pharm Res. 2022 Dec;…Freedom WaresFebruary 25, 2023
